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Tbx20During early embryogenesis, the formation of the cardiac atrioventricular canal (AVC) facilitates the transition of
the heart from a linear tube into a chambered organ. However, the genetic pathways underlying this develop-
mental process are poorly understood. The T-box transcription factor Tbx20 is expressed predominantly in the
AVC of early heart tube. It was shown that Tbx20 activates Nmyc1 and suppresses Tbx2 expression to promote
proliferation and speciﬁcation of the atrial and ventricular chambers, yet it is not known if Tbx20 is involved in
early AVC development. Here, we report that mice lacking Tbx20 in the AVC myocardium fail to form the AVC
constriction, and the endocardial epithelial–mesenchymal transition (EMT) is severely perturbed. Tbx20 main-
tains expression of a variety of genes, including Bmp2, Tbx3 and Hand1 in the AVCmyocardium. Intriguingly,
we found Bmp2 downstream genes involved in the EMT initiation are also downregulated. In addition, re-
expression of Bmp2 in the AVC myocardium substantially rescues the EMT defects resulting from the lack
of Tbx20, suggesting Bmp2 is one of the key downstream targets of Tbx20 in AVC development. Our data
support a complex signaling network with Tbx20 suppressing Tbx2 in the AVC myocardium but also indi-
rectly promoting Tbx2 expression through Bmp2. The spatiotemporal expression of Tbx2 in the AVC appears
to be balanced between these two opposing signals. Overall, our study provides genetic evidence that Tbx20
has essential roles in regulating AVC development that coordinate early cardiac chamber formation.rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Cardiac chamber formation represents an essential milestone in
evolution and is profoundly important for proper cardiac function
(Chi et al., 2008). In vertebrates, the emergence and subsequent de-
velopment of the atrioventricular canal (AVC), a cardiac component
that joins the primitive atria and ventricles, facilitates the transition
of the heart from a linear tube into a chambered organ. Along with
evolution, the high-volume low-pressure cardiovascular system of
the tunicates developed into a low-volume high-pressure system in
vertebrates (Moorman and Christoffels, 2003). Therefore, a proper
development of the AVC is crucial for cardiac chamber formation.
T-box genes encode transcription factors that have vital roles in organ-
ogenesis (Naiche et al., 2005). Tbx20 is an ancient T-box family member
with orthologues conserved from Drosophila to human (Plageman and
Yutzey, 2005), and is essential for heart development in different species
(Brown et al., 2005; Qian et al., 2008; Szeto et al., 2002). In mammals,Tbx20 is expressed in the heart throughout gestation (Carson et al.,
2000; Kraus et al., 2001). Mice lacking Tbx20 (Tbx20−/−) die at E9.5–
E10.5 with severely hypoplastic heart tubes. Tbx20 promotes Nmyc1
and suppresses Tbx2 in the chamber myocardium, which is crucial for
the chamber myocardial proliferation and speciﬁcation (Cai et al., 2005;
Singh et al., 2005; Stennard et al., 2005; Takeuchi et al., 2005). Recent
studies also revealed that TBX20 mutations are associated with human
congenital heart disease (CHD) (Kirk et al., 2007; Liu et al., 2008; Qian
et al., 2008).
Previous studies indicated that vertebrate AVC development is regu-
lated by bone morphogenetic proteins (Bmps). In mouse, Bmp2 is the
earliest knownmarker expressed in the precursors of AVCmyocardium.
Bmp2 regulates early AVC development by activating Tbx2, Msx2 and
Has2 in the AVC myocardium (Ma et al., 2005; Rivera-Feliciano and
Tabin, 2006). In addition, Bmp2 signals mediate Twist1, Msx1 and
Smad6 expression in the AVC endocardium to modulate EMT and AVC
cushion formation. Another Bmp gene, Bmp4, is expressed in the outﬂow
tract (OFT) and atrioventricular valves. Disruption of Bmp4 in mouse
heart leads to OFT and AVC septation defects at mid-late gestation (Jiao
et al., 2003; Liu et al., 2004; McCulley et al., 2008).
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development. Murine Tbx2 and Tbx3 are speciﬁcally expressed in the
AVC of the early heart. Tbx2 expression is activated by Bmp2 whereas
the signals activating Tbx3 are unknown. Tbx2 and Tbx3 suppress the
chamber speciﬁcation program in AVC and OFT cells (Aanhaanen
et al., 2009; Christoffels et al., 2004; Habets et al., 2002; Harrelson
et al., 2004; Hoogaars et al., 2007; Ribeiro et al., 2007). Disruption of
Tbx2or Tbx3 inmouse embryos causes variable defects, including effects
in AVC and OFT development (Aanhaanen et al., 2009; Christoffels et al.,
2004; Habets et al., 2002; Harrelson et al., 2004; Hoogaars et al., 2007;
Ribeiro et al., 2007). The basic helix–loop–helix transcription factors
Hesr1 (Hey1) and Hesr2 (Hey2) are expressed in the atrium and ventri-
cle, respectively. They regulate AV boundary formation by suppressing
Bmp2 and Tbx2 expression in the cardiac chambers (Kokubo et al.,
2007; Rutenberg et al., 2006). As in mouse, zebraﬁsh Tbx2a (orthologue
of murine Tbx2) and Tbx3b (orthologue of murine Tbx3) are expressed
in the AVC andOFT. They inhibit cell proliferation and repress the cham-
ber genetic program during heart remodeling (Ribeiro et al., 2007). In
addition, zebraﬁsh Forkhead transcription factor Foxn4 activates
Tbx2b in the AVC to contribute atrial and ventricular septation (Chi
et al., 2008).
During early embryogenesis in mouse, Tbx20 suppresses Bmpme-
diated Tbx2 activity in the cardiac chambers by interacting with
Smad1/5 (Singh et al., 2009). Although this mechanism may explain
why Tbx2 expression is conﬁned to the AVC, it does not address the
role of Tbx20 itself in AVC development. This is even more pertinent
as in mouse and chicken, Tbx20 is expressed at strikingly higher
level in the AVC and OFT than in the chamber cardiac cells (Dupays
et al., 2009; Shelton and Yutzey, 2007; Stennard et al., 2003; Takeuchi
et al., 2005). In this study, we speciﬁcally deleted Tbx20 in the AVC
myocardium by crossing Tbx20-ﬂoxed mice (Tbx20ﬂox/ﬂox) to Tbx2-
Cre mice (Tbx2Cre/+). We found that mutant embryos display severe
AVC constriction defects with a lack of cushion mesenchymal cells.
Tbx20 regulates EMT through Bmp2 expression, whereas a role of en-
docardial Tbx20 is excluded. Our data show that, in addition to pro-
moting chamber myocardial proliferation and speciﬁcation (Cai
et al., 2005; Singh et al., 2005; Stennard et al., 2005; Takeuchi et al.,
2005), Tbx20 is also essential for mediating AVC patterning. There-
fore, Tbx20 plays crucial roles in these two important aspects of
early heart development.
Materials and methods
Animals
Tbx20-ﬂoxed mice (Tbx20ﬂox/ﬂox or Tbx20f/f) were generated by
ﬂanking exon 2 with two LoxP sites. Cre-mediated excision of exon
2 shifts Tbx20 reading frame and obliterates the T-box DNA binding
domain (Cai et al., 2005). Tbx2-Cre (Tbx2Cre/+) knock-in mice and
Tie2-Cre (Tie2Cre) transgenic mice have been described (Aanhaanen
et al., 2009; Kisanuki et al., 2001). Bmp2 transgenic mice were gener-
ated with a vector containing a ubiquitously expressing CAG promot-
er (CMV-βactin-intron), followed by a LoxP-eGFP-STOP-LoxP cassette
(Collombat et al., 2009). The full-length Bmp2 cDNA was inserted
with an IRES-LacZ cassette. The puriﬁed DNA fragments were micro-
injected into B6C3 mouse zygotes to generate transgenic animals.
All mice were bred in a mixed genetic background (Black Swiss) for
analysis.
Whole-mount RNA in situ hybridization and histology
Whole-mount RNA in situ hybridization of mouse embryos was
carried out according to Wilkinson's protocol (Wilkinson, 1992). For
histology, mouse embryos were ﬁxed in 4% paraformaldehyde, dehy-
drated through graded ethanol and embedded in parafﬁn. Parafﬁnsections were cut at 8 μm thickness and stained with hematoxylin–
eosin as needed.
X-gal and Alcian blue staining
Mouse embryos were ﬁxed in 4% paraformaldehyde for 30 min.
After permeabilization (10% Na deoxycholate, 10% NP40 in PBS), em-
bryos were stained in X-gal solution (50 mM K-ferricyanide, 50 mM
K-ferrocyanide, 200 mM MgCl2, 100 mg/ml X-gal in PBS) for 12 h.
For Alcian blue staining, tissues from parafﬁn sections were rehy-
drated and stained in 3% Alcian blue solution (pH 2.5) for 30 min,
washed in tap water and counterstained with nuclear fast red by a
standard procedure (Bancroft and Gamble, 2008).
Proliferation and apoptosis analysis
Mitotic and apoptotic cellswere examinedwith anti-phosphohistone
H3 (pH3) antibody (Millipore, 1:100 dilution) and an in situ cell death
detection kit (Roche). Alexa 488 conjugated anti-rabbit antibody (Invi-
trogen, 1:500 dilution) and DAPI were used to detect pH3 and nuclei, re-
spectively. Embryos were embedded in parafﬁn, sectioned, and
immunostained.
Statistic analysis of AVC mesenchymal cells
At least three embryos of each genotype were embedded in paraf-
ﬁn. Sagittal sections were performed to examine AVC mesenchymal
cells. Five sections of each embryo were counted. Independent count-
ing and statistic assays were carried out by two different individuals.
The results are shown as mean±S.D. values. A Student's t-test was
used to determine differences between every two groups.
Quantitative real-time PCR analysis
Heart tissues from E9.5 embryos were collected and total RNA
was isolated with Trizol (Invitrogen). First-strand cDNA was synthe-
sized by QuantiTect Reverse Transcription Kit (Qiagen). Real-time
PCR was performed using QuantiTect SYBR Green PCR Kit (Qiagen),
and was normalized to β-actin with the following primers: β-actin
5′-TGAACCCTAAGGCCAACCGTGAAA-3′ and 5′-CAGGATGGCGT-
GAGGGAGAGCATAG-3′, αMhc 5′-GTATGTTAAGGCCAAGGTCGTG-3′
and 5′-GTGCAGGAAGGTCAGCATG-3′, βMhc 5′-ACTGCTGAGACGGA-
GAATGG-3′ and 5′-CAGAAGAGGCCCGAGTAGG-3′, Mlc2a 5′-GGCA-
CAACGTGGCTCTTCTAA-3′ and 5′-GATTTGCAGATGATCCCATCCC-3′,
Tbx2 5′-TTCCACAAACTGAAGCTGAC-3′ and 5′-GCTGTGTAATCTTGT-
CATTCTG-3′. Real-time PCR results represent three independent ex-
periments with reactions performed in triplicate. A Student's t-test
was applied for statistical analysis.
Results
Myocardial Tbx20 is required for early AVC development
Tbx20 is differentially expressed in the early heart tube of mouse
embryos, exhibiting much higher levels of expression in the AVC
and OFT (including myocardial, endocardial and cushion mesenchy-
mal cells) than in chamber cardiac cells (Dupays et al., 2009; Stennard
et al., 2003; Takeuchi et al., 2005). We conﬁrmed this observation by
whole-mount RNA in situ hybridization of mouse embryos (E9.0–9.5
with short time staining) (Fig. 1A–D).
To investigate a role for Tbx20 in the AVC formation, we crossed
Tbx20f/f mice to Tbx2Cre/+ mice. Tbx2Cre/+ is a knock-in mouse model
that speciﬁcally drives Cre expression in the AVC and OFT myocardi-
um as early as E8.5 (Aanhaanen et al., 2009 and Fig. S1). Mice with
heterozygous deletion of Tbx20 (Tbx2Cre/+;Tbx20f/+) were viable and
normal, while Tbx2Cre/+;Tbx20f/f mice (Tbx20 conditional knockout
Fig. 1.Myocardial Tbx20 is required for early AVC development. (A–D) Whole-mount RNA in situ hybridization with a brief staining time shows Tbx20 is unevenly expressed in the
heart at E9.0–9.5, exhibiting much higher levels of expression in the AVC and OFT (arrows in A, C) than in the chamber cardiac cells (atria and ventricles). Sagittal sections conﬁrm
the stronger expression of Tbx20 in the AVC and OFT in both myocardium (arrows in B, D) and endocardium, as well as cushion mesenchymal cells (asterisks in B, D). (E,F) Left
lateral views of Tbx20 CKO mutants (F, Tbx2:Cre;Tbx20:f/f) and control littermates (E, Tbx2:Cre;Tbx20:f/+) at E9.5. Less AVC constriction is observed in the mutants (arrows in
E–H). G/H are sagittal sections for E/F, respectively. While AVC cushion mesenchymal cells are apparent at E9.5 (asterisk in G and arrows in I), very few mesenchymal cells
are detected in the mutants (asterisk in H and arrows in J). I/J are high magniﬁcation images for G/H in the AVC (squares), respectively. LV, left ventricle; LA, left atrium.
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duced AVC constriction when compared to their heterozygous litter-
mates at E9.5 (Fig. 1E, F). The defects could be detected as early as
E9.0 (data not shown). In addition, while AVC cushion mesenchymal
cells were present in the control hearts from E9.5, very few mesen-
chymal cells were observed in the mutants (Fig. 1G–J, and data not
shown for later stages).
Myocardial differentiation and chamber speciﬁcation occurred in Tbx20
CKO mutants
To determine if the AVC defects in Tbx20 CKO embryos reﬂected
abnormal myocardial differentiation, we assayed expression of
markers for differentiated myocardium, including αMhc (Myh6),
βMhc (Myh7) and Mlc2a (Myl7). αMhc was restricted to the AVC
and forming atria at early stages, and βMhc andMlc2awere expressed
throughout the myocardium. We examined expression of these genes
with RNA in situ hybridization and quantitative RT-PCR. No signiﬁcant
difference in expression localization was observed from the RNA in
situ hybridization assays (Fig. S2 A–F). Quantitative RT-PCR detected
that αMhc was downregulated (13.3%) and βMhc was upregulated
(19.9%), both signiﬁcant but very modest differences (Fig. S2 G);
Mlc2a expression level was unchanged. These observations demon-
strate that the myocardial differentiation program within the AVC
area had occurred in Tbx20 CKO mutants but was slightly perturbed.
We further examined the expression of key cardiac transcription
factors, including Nkx2.5, Gata4, Tbx5, Mef2c and Hand1, to determine
if Tbx20 regulates AVC myocardial formation by acting upstream of
them. Expression of most of these genes was unaffected in the
Tbx20 CKO mutants (Fig. S3 A–H). In contrast, Hand1, the basic
helix–loop–helix (bHLH) transcription factor that is normally
expressed in the AVC and left ventricular myocardium at E9.0, was
downregulated in the AVC region of mutant embryos (Fig. S3 I, J).
We speculate, however, that reduced Hand1 expression is not the
main cause for the AVC defects observed in the mutants, given that
cardiac deletion of Hand1 results in much less perturbation of early
heart development (McFadden et al., 2005). We also examined theproliferating and apoptotic cells in the AVCmyocardium and did not de-
tect signiﬁcant differences between the mutant and control embryos
(Fig S4).
During early cardiogenesis, Tbx2 is speciﬁcally expressed in the
myocardial layer of the AVC and OFT (Harrelson et al., 2004 and Fig.
S1). In chamber myocardium, Tbx20 represses Tbx2 expression (Cai
et al., 2005; Singh et al., 2005; Stennard et al., 2005; Takeuchi et al.,
2005). Because Tbx20 and Tbx2 are co-expressed in the AVC region,
we wanted to determine if Tbx20 alters (activates) Tbx2 expression
in the AVC myocardium. As shown in Fig. 2A–I, Tbx2 expression was
not signiﬁcantly changed in the AVC region of the mutant embryos.
These data indicate that Tbx20 does not activate Tbx2 in the AVC
myocardium.
To further investigate the chamber speciﬁcation of Tbx20 CKO em-
bryos, particularly whether the mutant hearts retained proper cham-
ber and AVC identities, we examined the expression of the chamber-
speciﬁc genes, Nppa (Anf) and Gja5 (Cx40). Nppa and Gja5maintained
their “localized” expression in the chamber myocardium (atria and
ventricles), and neither was ectopically expressed in the AVC
(Fig. 2J–M), indicating that the mutant embryos still possessed proper
chamber and AVC identities. The basic helix–loop–helix transcription
factors Hesr1 and Hesr2were speciﬁcally expressed in the atrium and
ventricle, respectively, and they play crucial roles in the AV boundary
formation by suppressing Bmp2 and Tbx2 in the chamber myocardi-
um (Kokubo et al., 2007; Rutenberg et al., 2006). We found Hesr1
and Hesr2 expression was unaffected in the AVC and chamber regions
(Fig. 2N–Q). The relatively normal expression of the chamber-speciﬁc
genes suggests that the chamber speciﬁcation still occurs in Tbx20 CKO
embryos, and unlike Tbx2, Tbx20 does not repress chamber-speciﬁc
genes in the AVC.
Bmp2 expression is downregulated in the AVC myocardium of Tbx20 CKO
embryos
Bmp2 is the earliest knownmarker expressed in the AVCmyocardium
and is critical for earlyAVCdevelopment (Maet al., 2005; Rivera-Feliciano
and Tabin, 2006; Yamada et al., 2000). In chick andmouse, Bmp2 induces
Fig. 2. Cardiac chamber speciﬁcation is not perturbed in Tbx20 CKO embryos. Sagittal sections of embryos showing expression of genes. During early cardiogenesis, Tbx2 is expressed
in the AVC myocardium (arrows in A, C, E, G). Expression of Tbx2 is maintained in the AVC of Tbx20 CKO embryos (arrows in B, D, F, H). C/D and G/H are sagittal sections of A/B and
E/F, respectively. (I) Quantitative RT-PCR reveals that Tbx2 expression level is not signiﬁcantly changed (n.s., not signiﬁcant). Expression of chamber speciﬁcation genes, Nppa (J/K,
atrium and ventricle speciﬁc), Gja5 (L/M, atrium and ventricle speciﬁc), Hesr1 (N/O, atrium speciﬁc) and Hesr2 (P/Q, ventricle speciﬁc), is unchanged in the chamber myocardium of
Tbx20 CKO mutants. Arrows indicate the AVC region. LV, left ventricle; LA, left atrium.
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2006; Yamada et al., 2000).Micewith cardiac deletion ofBmp2 exhibit se-
vere AVC constriction defects, lack of endocardial cushion EMT, and loss
of Tbx2 expression (Ma et al., 2005; Rivera-Feliciano and Tabin, 2006;
Yamada et al., 2000). Although Bmp2 acts as an upstream activator forFig. 3. Bmp signaling in Tbx20 CKO embryos. (A–H) Bmp2 expression is signiﬁcantly downreg
are sagittal sections for A/B and E/F in the heart, respectively. (I–L) Bmp4 is speciﬁcally expre
in the OFT (arrow in J), it is ectopically expressed at very low level in the AVC of mutant hear
tants. Arrows indicate the AVC region. LV, left ventricle; LA, left atrium.Tbx2 expression, the signals inducing Bmp2 expression in the AVC myo-
cardium are unknown.
We determined if Tbx20 controls Bmp2 expression in the AVC
myocardium. Interestingly, Bmp2 expression was dramatically down-
regulated in the Tbx20 CKO hearts (Fig. 3A–H). We further checkedulated in the AVCmyocardium of Tbx20 CKOmutants at E9.0–9.5 (arrows). C/D and G/H
ssed in the OFT in the early heart tube (arrow in I). While Bmp4 expression is unchanged
ts (arrows in K, L). Bmp7 (M, N) and Bmp10 (O, P) expression are unaffected in the mu-
385X. Cai et al. / Developmental Biology 360 (2011) 381–390the expression of additional Bmp genes as they share important roles
in heart development. Bmp4 expression was unchanged in the OFT
(Fig. 3I, J), but was ectopically expressed at very low level in the
AVC (Fig. 3K, L). Expression of Bmp7 and Bmp10 in the mutant hearts
was unchanged (Fig. 3M–P).
Tbx20 is a key upstream regulator for AVC development
During early heart development, Tbx3 is co-expressed with Tbx2 in
the AVC myocardium (Hoogaars et al., 2007; Mesbah et al., 2008).
Tbx3 and Tbx2 suppress AVC myocardial proliferation to promote car-
diac chamber formation (Aanhaanen et al., 2009; Christoffels et al.,
2004; Habets et al., 2002; Harrelson et al., 2004; Hoogaars et al.,
2007; Ribeiro et al., 2007). We found Tbx3 expression was remarkably
downregulated in Tbx20 CKO embryos (Fig. 4A–D). Transforming
growth factor β2 (Tgfβ2) and the msh homeobox transcription factor
Msx2 are speciﬁcally expressed in the AVC myocardium. They act as
downstream of Bmp2 and are activated by Bmp2 signals (Ma et al.,
2005; Rivera-Feliciano and Tabin, 2006). Tgfβ2 induces EMT initiation
(Person et al., 2005), and Msx2 is essential for AVC endocardial EMT
and myocardial patterning (Chen et al., 2008). Expression of Tgfβ2
and Msx2 was completely absent in the AVC myocardial cells of
Tbx20 CKO embryos (Fig. 4E–L).
Extracellular matrix (ECM) formation is crucial for EMT (Camenisch
et al., 2000). To determine whether the AVC cushion development of
the mutant embryos results from defective ECM, we performed Alcian
blue staining to examine ECM integrity. As shown in Fig. 5, ECM in the
cardiac jelly was intact in the mutants (Fig. 5A, B), suggesting the EMT
defects of Tbx20 CKO embryos were not due to a defective ECM forma-
tion. Hyaluronic acid (HA) synthase 2 (Has2), a major enzyme for HA
synthesis, is expressed in both AVC myocardium and endocardiumFig. 4. Aberrant AVCmyocardium development programs in Tbx20 CKO embryos. At E9.5, Tbx
and I/K). Expression of these genes is severely downregulated in Tbx20 CKOmutants (arrows
respectively. LV, left ventricle; LA, left atrium.(Fig. 5C, E) and is essential for ECM formation. In agreement with the
Alcian blue staining, Has2 expression was unaltered in the endocardial
cells of the mutant embryos (Fig. 5C–F), yet the myocardial expression
wasmissing, suggesting thatHas2 expression in the AVCmyocardium is
also maintained by Tbx20.Tbx20 regulates EMT in a non-cell-autonomous manner
The transcription factors Sox9, Twist1 and Msx1 are speciﬁcally
expressed in the AVC cushion mesenchyme and crucial for the prolif-
eration and migration of these cells (Akiyama et al., 2004; Chen et al.,
2008; Shelton and Yutzey, 2008). Expression of Sox9, Twist1 andMsx1
was absent in the Tbx20 CKO mutants (Fig. 6A–L), consistent with the
prior observation that mutant embryos lack AVC cushion mesenchy-
mal cells (Fig. 1G–J). The early endocardial markers Notch1 and VE-
Cadherin were still expressed in Tbx20 CKO hearts, suggesting that
early AVC endocardium development was unaffected in the mutant
embryos (Fig. 6M–T).
As Tbx20 has been implicated for promoting endocardial cushion
cell proliferation during heart development (Shelton and Yutzey,
2007), and Tbx20 is strongly expressed in the AVC endocardium and
cushion mesenchyme (Fig. 1A–D), we asked whether loss of Tbx20
in these cells could also affect early EMT and AVC formation. By cross-
ing Tbx20f/f mice to Tie2Cre mice, speciﬁcally deleting Tbx20 in the en-
docardium and cushion mesenchyme (Fig. 7G, I) (Kisanuki et al.,
2001), we found mutant embryos (Tie2Cre;Tbx20f/f) had grossly nor-
mal cardiac shape at E9.5–10.0 (Fig. 7A–F), and the number of AVC
cushion mesenchymal cells was similar to their control littermates
at E10.0 (Fig. 7H, J), indicating that loss of Tbx20 in the endocardium
and cushion mesenchyme did not inhibit EMT. These observations3, Tgfβ2 andMsx2 are speciﬁcally expressed in the AVCmyocardium (arrows in A/C, E/G
in B/D, F/H and J/L). C/D, G/H and K/L are sagittal sections for A/B, E/F and I/J in the hearts,
Fig. 5. ECM integrity of AVC endocardial cushion is unaffected in Tbx20 CKO hearts. Alcian blue staining reveals ECM integrity of the AVC cardiac jelly is unaffected in the mutant
hearts (arrows in A, B). Has2, a synthetic enzyme for hyaluronic acid (HA), is speciﬁcally expressed in the AVC myocardium (arrows in C, E) and endocardium (asterisks in E). Al-
though Has2 expression is absent in the AVC myocardium of Tbx20 CKO mutant (arrows in D, F), the endocardial expression is maintained (asterisks in F), suggesting HA synthesis
still occurs in the ECM of mutant embryos. LV, left ventricle; LA, left atrium.
386 X. Cai et al. / Developmental Biology 360 (2011) 381–390further suggest that the myocardial Tbx20 expression modulates EMT
during early AVC development.
Re-expression of Bmp2 substantially rescues EMT defects in Tbx20 CKO
hearts
Our results revealed that two categories of genes were altered in
Tbx20 CKO hearts: 1) Tgfβ2, Msx2 and Has2 expression was missing
in the AVC myocardium; 2) Sox9, Twist1 and Msx1 expression was
missing in the AVC cushion mesenchyme (or absence of AVC cushion
mesenchymal cells). Intriguingly, these altered gene expressions are
completely reminiscent of that observed in Bmp2 cardiac deletion
mouse embryos (Ma et al., 2005; Rivera-Feliciano and Tabin, 2006).
In addition, Tbx20 CKO and Bmp2 cardiac deletion embryos displayed
similar AVC constriction and cushion development defects (Fig. 1E–J
and Ma et al., 2005; Rivera-Feliciano and Tabin, 2006). TheseFig. 6. Disrupted AVC cushion mesenchyme formation in Tbx20 CKO embryos. Sox9, Twist1 a
E/G,I/K). Expression of these genes is nearly absent in Tbx20 CKO hearts (B/D, F/H,J/L). Notc
Tbx20 CKO embryos. Arrows indicate the AVC region. LV, left ventricle; LA, left atrium.observations led us to hypothesize that Tbx20 regulates early AVC
and EMT development through Bmp2.
To further characterize the regulatory interaction between Tbx20
and Bmp2, particularly whether Bmp2 is a key downstream factor of
Tbx20 during the AVC formation and EMT initiation, we generated a
transgenic mouse model with a conditional Bmp2 expression vector
(CAG-LoxP-eGFP-STOP-LoxP-Bmp2-IRES-LacZ), to force re-expression
of Bmp2 in the AVC myocardium of Tbx20 CKO embryos (Fig. 8A). In
this model, eGFP expression is under the control of a ubiquitously
expressed CAG promoter. Bmp2 expression is initiatedwhen Cre excises
the eGFP-STOP cassette. We applied Tbx2Cre to efﬁciently re-express
Bmp2 in the AVC myocardium (Fig. 8A3/4). Compared with the Tbx20
CKOmutants, we found a signiﬁcantly increased number of AVC cushion
mesenchymal cells in themutant embryos expressing Bmp2 in the Tbx2
domain (17.8±3.9 cells, n=5, Fig. 8J, K), with numbers approaching
those seen in the control littermates (22.3±0.9 cells, n=5, Fig. 8H, K),nd Msx1 are speciﬁcally expressed in the AVC cushion mesenchymal cells at E9.5 (A/C,
h1 (M-P) and VE-Cadherin (Q-T) expression is maintained in the AVC endocardium of
Fig. 7. EMT initiation in AVC is independent of endocardial Tbx20. (A–F) Whole-mount views of mouse embryos with Tbx20 deletion in the endocardium and cushion mesenchyme
by Tie2Cre. Unlike Tbx20 CKO embryos, Tie2Cre;Tbx20f/f hearts do not display morphogenetic defects at E9.5-E10.0. Arrows in A-F indicate OFT or AVC. (G–J) Sagittal sections of mouse
hearts at E10.0. Embryos contain one copy of R26RlacZ to determine Tie2Cre lineage cells with disrupted Tbx20 allele. X-gal staining shows Tie2Cre lineage cells including endocardium
and cushion mesenchyme (G,I). As in the controls (arrows in I), AVC endocardium and cushion mesenchymal cells are still well formed in the mutants at E10.0 (arrows in J). I/J are
high magniﬁcation images for G/H in the AVC (square area), respectively. LV, left ventricle; LA, left atrium.
387X. Cai et al. / Developmental Biology 360 (2011) 381–390while very fewmesenchymal cells were observed in themutant embry-
os (2.8±1.4 cells, n=3, Fig. 8I, K). We further performed RNA in situ
hybridization with Sox9, a speciﬁc marker for AVC mesenchymal cells.
Sox9 was re-expressed in the AVC region of the “rescued” embryosFig. 8. Genetic rescue of EMT defects by re-expression of Bmp2 in Tbx20 CKO embryos. (A)
eGFP-STOP-LoxP) followed by a Bmp2-IRES-lacZ cassette is driven by a ubiquitously express
embryo (A3). Bmp2 expression is activated when Cre excises the eGFP-STOP cassette. The tra
(A2). X-gal staining is performed to evaluate Bmp2 expression in Tbx2Cre;Bmp2-Tg+ embryo
(C, Tbx2Cre;Tbx20f/f;Bmp2-Tg−) and “rescued” (D, Tbx2Cre;Tbx20f/f;Bmp2-Tg+) embryos at E9.5
parisons for B/C/D, arrows). (E–J) Sagittal sections reveal that the migrating cushion mesenc
the control littermates (E, arrows in H). Very few mesenchymal cells are observed in the mu
region (squares), respectively. (K) Statistic analysis indicates a signiﬁcantly increased numb
statistic assays are conﬁrmed by two analysts. Results are obtained from ﬁve control, three m
of mesenchymal cells, is re-expressed in the AVC region of “rescued” embryos. Arrows indi(Fig. 8L–N), indicating a recovery formation of AVC mesenchymal
cells. We also checked Tbx2 expression in the “rescued” embryos, and
found it was still expressed in the AVC region (Fig. S5). These results
show that re-expression of Bmp2 rescues EMT defects of Tbx20 CKODiagram for Bmp2 conditional expression transgenic construct. The ﬂoxed eGFP (LoxP-
ing CAG promoter (A1). Visualization of GFP expression in heart on an E9.5 transgenic
nsgenic mouse line is crossed to Tbx2:Cremice for re-expression of Bmp2 in Tbx2+ cells
s (A4). (B–D) Left lateral views of the control (B, Tbx2Cre;Tbx20f/+;Bmp2-Tg−), mutant
. The defects of AVC constriction are slightly attenuated in the “rescued” embryos (com-
hymal cells are obviously formed in the “rescued” embryos (G, arrows in J), resembling
tant littermates (F, arrows in I). H/I/J are high magniﬁcation images for E/F/G in the AVC
er of mesenchymal cells in the AVC region of “rescued” embryos. Separate counting and
utant and ﬁve “rescued” littermate embryos. *pb0.01 vs. mutant. (L–N) Sox9, a marker
cate the AVC region. LV, left ventricle; LA, left atrium.
388 X. Cai et al. / Developmental Biology 360 (2011) 381–390embryos, supporting the idea that downregulation of Bmp2 is the main
cause of the EMT defects in the mutant embryos. In addition, the “res-
cued” embryos displayed mitigated AVC constriction (Fig. 8B–D). Nota-
bly, re-expression of Bmp2did not fully rescue the cardiac development,
and the resulting embryos could not survive beyond E10.5. These ﬁnd-
ings indicate that the regulation of Bmp2 by Tbx20 is a critical, but not
the exclusive, factor in AVC development.
Discussion
In this study, we deleted Tbx20 in the AVC myocardium by cross-
ing Tbx20f/fmice to Tbx2Cre/+mice. The mutant embryos displayed se-
verely underdeveloped AVC constriction with loss of cushion
mesenchymal cells (Fig. 1E–J), demonstrating that Tbx20 is essential
for early AVC formation. Given that Tbx20 is highly expressed in the
AVC endocardium and cushion mesenchymal cells (Fig. 1A–D), we
further eliminated Tbx20 in these cells by crossing Tbx20-ﬂoxed
mice to Tie2Cre mice. The grossly normal cardiac morphology of
Tie2Cre;Tbx20f/f embryos (E9.5–10.0) indicates that the expression of
Tbx20 in the AVC myocardium, not in the endocardium or cushion
mesenchyme, controls EMT initiation (Fig. 7). Re-expression of
Bmp2 in the AVC myocardium rescued the EMT defects of Tbx20
CKO hearts, suggesting that Tbx20 regulates EMT through Bmp2
(Fig. 8). It is also important to note that, although EMT defects were
not observed in Tie2Cre;Tbx20f/f hearts by E10.0 (Fig. 7), Tbx20 may still
be important for AVC cushion and valve formation at later gestational
stages in mice, as suggested in studies of chick embryos (Shelton and
Yutzey, 2007).
Several studies have indicated that Bmp2 is the earliest gene
expressed in the AVC myocardium, and Bmp2 induces Tbx2 expres-
sion during AVC formation (Ma et al., 2005; Rivera-Feliciano and
Tabin, 2006; Yamada et al., 2000) (Bmp2→Tbx2, Fig. 9). Bmp2 alsoFig. 9. Schematic illustration of Tbx20 regulatory cascades and genetic interactions of
Tbx20, Bmp2 and Tbx2 during early AVC development. During early cardiogenesis,
Tbx20 is predominantly expressed in the AVC myocardium. Upon regulation by
Tbx20 as well as other factors, Bmp2 is expressed and it further activates Tgfβ2, Msx2
and Has2 in the myocardium (Ma et al., 2005; Rivera-Feliciano and Tabin, 2006).
Bmp2 also regulates EMT in AVC through promoting Sox9, Twist1 and Msx1 expression
in the cushion mesenchyme (Ma et al., 2005; Rivera-Feliciano and Tabin, 2006). Tbx20
is required for EMT initiation through regulation of Bmp2 in the AVC myocardium.
Tbx20 also maintains Tbx3 and Hand1 expression in the AVC myocardium. Tbx2 expres-
sion is induced by Bmp2 (Ma et al., 2005; Rivera-Feliciano and Tabin, 2006; Yamada
et al., 2000), and is possibly still repressed by Tbx20. Tbx2 represses chamber-speciﬁc
genes expression (e.g., Nppa, Gja5) in the AVC myocardium (Christoffels et al., 2004;
Harrelson et al., 2004). LV, left ventricle; LA, left atrium.activates Tgfβ2, Msx2 and Has2 in the AVC myocardium, and initiates
EMT by regulating Sox9, Twist1 andMsx1 expression in the AVC cushion
mesenchyme (Ma et al., 2005; Rivera-Feliciano and Tabin, 2006) (Fig. 9).
A recent study also revealed that Bmp2 integrates with endocardial
Notch signals to promote EMT (Luna-Zurita et al., 2010). Although the
genes downstream of Bmp2 are well characterized, the upstream signals
for induction of Bmp2 expression are largely unknown. We found that
Tbx20 is important to maintain Bmp2 expression in the AVC myocardi-
um, identifying Tbx20 as the earlier regulator for this key aspect of heart
development (Tbx20→Bmp2, Fig. 9). Additional as-yet-unidentiﬁed
factors may also contribute to Bmp2 activation because Bmp2 tran-
scripts were not completely eliminated (although mostly) in Tbx20
CKO hearts (Fig. 3A–H, Fig. 9). In addition, we found that Tbx20 pro-
motes other key transcription factors, including Tbx3 andHand1 expres-
sion in the AVCmyocardium (Fig. 3A–D, Fig. S3 I, J, and Fig. 9). Although
individual disruption of these genes does not cause severe defects rem-
iniscent of Tbx20 CKO embryos (McFadden et al., 2005; Mesbah et al.,
2008), their dysregulation may still contribute to certain aspects of car-
diac malformations in the mutant embryos. This may also explain why
re-expression of Bmp2 cannot fully rescue AVC constriction defects of
Tbx20 CKO embryos, although the EMT and cushion development is
largely recovered.
During early cardiogenesis, Tbx2 is speciﬁcally expressed in the
AVC to repress chamber-speciﬁc gene expression (Christoffels et al.,
2004; Harrelson et al., 2004) (Tbx2–|Nppa/Gja5, Fig. 9). In the cham-
ber myocardium, Tbx20 acts as a transcriptional suppressor for Tbx2
such that its expression is not detectable (Cai et al., 2005; Singh
et al., 2005; Stennard et al., 2005; Takeuchi et al., 2005). Tbx20 may
interfere with Bmp/Smad signaling to inhibit Tbx2 expression in the
cardiac chambers to conﬁne Tbx2 expression in the AVC (Singh
et al., 2009). Although Tbx20 suppressing Tbx2 transcription in the
chamber myocardium has been well recognized, it was not known
whether and how Tbx20 regulates Tbx2 expression in the AVC. In
Tbx20 CKO embryos, we detected a relatively normal Tbx2 expression
and a dramatically downregulated Bmp2 expression in the AVC myo-
cardium. As Bmp2 is essential for Tbx2 expression in the AVC
(Bmp2→Tbx2) (Ma et al., 2005; Rivera-Feliciano and Tabin, 2006;
Yamada et al., 2000), we anticipated a downregulated Tbx2 expres-
sion in the AVC of mutant hearts. In fact, Tbx2 expression was not sig-
niﬁcantly decreased in the AVC region (Fig. 2A–I). Based on these
observations, we speculate that Tbx20 still acts as a suppressor for
Tbx2 expression in the AVC myocardium (Fig. 9). The reason that
Tbx2 expression was not downregulated in the mutant embryos
(which was expected due to loss of Bmp2 activation) was because it
may be mitigated by loss of Tbx20's direct repression. Therefore, the
spatiotemporal expression of Tbx2 may be regulated by two antago-
nistic signals: Tbx20–|Tbx2 and Tbx20→Bmp2→Tbx2 (Fig. 9), and
the high-level expression of Tbx20 in the AVC myocardium may play
an essential role for balancing of the antagonistic signals that further
affect early heart development.
Interestingly, a recent study revealed that Bmp/Smad1 signals di-
rectly activate Tbx20 cardiac expression in Xenopus (Mandel et al.,
2010). Mouse Bmp10 also induces Tbx20 expression in the ventricular
wall (Zhang et al., 2011). It is unclear, however, whether Bmps still
act as upstream regulators for activating Tbx20 expression in the
AVC region. In Bmp2 cardiac deletion mouse embryos, Tbx20 is still
normally expressed (Ma et al., 2005), indicating that Bmp2 itself is
not an upstream activator for Tbx20 expression in the AVC, and that
regulation of Bmp2 by Tbx20 is unidirectional. Collectively, these ob-
servations suggest that Bmp signals may act as either upstream or
downstream of Tbx20 during early heart formation.
It was shown that Tbx2 directly activates Has2 and Tgfβ2 activity
to mediate AVC endocardial cushion formation (Shirai et al., 2009).
In Tbx20 CKO embryos, Has2 and Tgfβ2 expression is absent whereas
Tbx2 is still expressed in the AVC myocardium. Thus, we suspect that
Has2 and Tgfβ2 may be regulated by both Tbx2 (Shirai et al., 2009)
389X. Cai et al. / Developmental Biology 360 (2011) 381–390and Tbx20/Bmp2 signals (Ma et al., 2005; Rivera-Feliciano and Tabin,
2006), and that Tbx20→Bmp2 pathways seem more effectively to
manipulate Has2 and Tgfβ2 activity during AVC formation.
Taken together, our studies provide genetic evidence that Tbx20
acts as a key upstream regulator for a variety of genes, especially
Bmp2, in the regulation of early AVC development. Our data also sug-
gest that, in addition to promoting chamber myocardial proliferation
and speciﬁcation (Cai et al., 2005; Singh et al., 2005; Stennard et al.,
2005; Takeuchi et al., 2005), Tbx20 is essential for AVC patterning
and cushion formation, therefore playing crucial roles in these two
important aspects to coordinate early heart development.
Supplementary materials related to this article can be found online
at doi:10.1016/j.ydbio.2011.09.023.
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